NP / PA
Smith, Marla
Smith, Marla was paid $246K by Medicaid between Jun 2019 and Nov 2024, across 25 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.
33Billing provider infoSMITH, MARLA
WATERLOO, IL 62298
WATERLOO, IL 62298
33aNPI1548444011assigned 12/20/2007
33bProvider typeWomen's Health Nurse Practitioner
28Total paid$246K
24GClaims5,934
24DCodes billed25
24AFirst – last monthJun 2019 – Nov 2024
Compared with peers
Next to other Women's Health Nurse Practitioner providers in Illinois
Rank by total paid#9 of 82
Median peer was paid$50K
This provider vs. median4.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 106 | $4K | |
| 2020 | 529 | $22K | |
| 2021 | 675 | $30K | |
| 2022 | 1,256 | $52K | |
| 2023 | 1,863 | $75K | |
| 2024incomplete | 1,505 | $62K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 1,093 | 876 | $59K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 17% | 512 | 433 | $41K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 485 | 378 | $39K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 9.6% | 553 | 472 | $24K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 9.5% | 552 | 470 | $23K |
| 0502F | 7.0% | 296 | 220 | $17K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 3.6% | 309 | 227 | $9K |
| 87511 | 3.0% | 170 | 127 | $7K | |
| 96127 | 2.6% | 460 | 395 | $6K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 2.6% | 151 | 100 | $6K |
| 81025 | 1.6% | 785 | 638 | $4K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1.4% | 120 | 94 | $3K |
13 more codes
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1.3% | 110 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 15 | $718.35 |
| 0500F | <1% | 13 | $518.20 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 17 | $416.60 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 18 | $392.02 |
| 81000 | <1% | 135 | $336.26 | |
| 99459 | <1% | 15 | $219.30 | |
| 86780 | <1% | 18 | $215.54 | |
| 86803 | <1% | 15 | $189.51 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 33 | $189.42 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 29 | $170.80 |
| 86762 | <1% | 15 | $151.05 | |
| 87340 | <1% | 15 | $137.19 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.